Treatment Registry
TR-0096 Not verifiedRecorded August 31, 2026Last verified September 2, 2026

Brand semaglutide

Sold by Effecty · Injection, pen · every brand semaglutide record

What you actually pay

Per month

$1,300

Medication · Ozempic (brand semaglutide, diabetes-labeled)$1,300

Added from the figures recorded below.

Price

TermPer monthCharged today
Ozempic (brand semaglutide, diabetes-labeled)

Ozempic® Starting at $1,300 /month

source

Per month$1,300Charged today$1,300
Wegovy (brand semaglutide, weight-loss-labeled)

Wegovy® Starting at $1,600 /month

source

Per month$1,600Charged today$1,600
Visit Effecty

We earn nothing from this link. Effecty has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Term added: Ozempic (brand semaglutide, diabetes-labeled)
  • September 2, 2026Term added: Wegovy (brand semaglutide, weight-loss-labeled)
  • September 2, 2026States changed
  • August 31, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed as of August 31, 2026
StatesNot disclosed as of September 3, 2026
PrescriberAsynchronous review
Cancellation“If you decide to cancel your subscription for any medication that has not yet been sent to the pharmacy for fullfillment, simply reach out to our customer support team. You can email us at hello@effecty.com with the subject line 'Cancel my account.' Our team will assist you with the cancellation process promptly and efficiently. Once the prescription has been sent to the pharmacy, you can only cancel your subscription for future shipments.”
Consult feeNot disclosed as of August 31, 2026

Not yet checked: membership.

Recorded from effecty.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. August 31, 2026Effecty prices most of its sixteen treatment cards on a 12-month term, not a monthly one. Eight are footnoted "* Price for purchase of 12 month supply.": compounded semaglutide, compounded tirzepatide, NAD+ injection, estradiol patch, glutathione, lipotropic MIC + B12, estradiol cream, estradiol tablet. Two are footnoted "* Price for purchase of 3 month supply.": sermorelin and sermorelin ODT. Six carry no footnote at all: NAD+ nasal spray, metformin, Mounjaro, Ozempic, Wegovy and Zepbound.
  2. 2. August 31, 2026The promo ladder, printed on both product pages the same day: "Use code SAVEMORE for up to $300 off — 1 MONTH $75 off — 3 MONTHS $125 off — 6 MONTHS $200 off — 12 MONTHS $300 off", with "Use code SAVEMORE for up to $300 off GLP-1" running as a marquee across the top of every page. None of it is included in the ladder above, which is the undiscounted rate.
  3. 3. August 31, 2026Brand prices from the home page, same day: "Mounjaro® Weight Loss $1,300 /month", "Ozempic® Weight Loss $1,300 /month", "Wegovy® Weight Loss $1,600 /month", "Zepbound® Weight Loss $1,400 /month". None carries a term footnote.
  4. 4. August 31, 2026The annual figures above are our multiplication of Effecty's own per-month rates, because Effecty publishes no totals: $130 × 12 = $1,560, $140 × 6 = $840, $150 × 3 = $450 for semaglutide; $190 × 12 = $2,280, $200 × 6 = $1,200, $210 × 3 = $630 for tirzepatide.
  5. 5. August 31, 2026Effecty is unambiguous that it stays out of insurance entirely. Its home page FAQ states: "Effecty does not accept insurance at this time ... Effecty doesn't provide superbills or communicate with insurance carriers in any case ... Effecty staff do not and will not communicate with insurance carriers about claims in any case."

3 further notes concern other Effecty programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0096
Readings
2

Related records

What else Effecty sells

All Effecty programs and terms

Brand semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 67 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Effecty brand semaglutide (TR-0096). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0096

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.